Published in J Clin Oncol on May 01, 1994
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
The anticancer immune response: indispensable for therapeutic success? J Clin Invest (2008) 4.01
Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci U S A (1998) 2.50
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A (1998) 2.29
Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity. Proc Natl Acad Sci U S A (1996) 1.85
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design. Semin Immunopathol (2011) 1.80
Immunotherapy for melanoma: current status and perspectives. J Immunother (2010) 1.72
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc Natl Acad Sci U S A (1999) 1.63
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature (2007) 1.51
Cancer vaccines and carbohydrate epitopes. Vaccine (2011) 1.40
Traveling for the glycosphingolipid path. Glycoconj J (2001) 1.16
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol (2004) 1.16
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells. Clin Cancer Res (2009) 1.15
Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg (2002) 1.15
Immunotherapy for cancer: synthetic carbohydrate-based vaccines. Chem Commun (Camb) (2009) 1.14
Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice. Proc Natl Acad Sci U S A (2001) 1.12
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes. Ann Surg (2002) 1.11
Utility of adjuvant systemic therapy in melanoma. Ann Oncol (2009) 1.10
Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens. Proc Natl Acad Sci U S A (2000) 1.02
From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine. J Am Chem Soc (2009) 1.01
Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience. Expert Rev Vaccines (2009) 1.01
Adjuvant therapy for melanoma. Cancer J (2012) 1.01
Recent Development in Carbohydrate Based Anti-cancer Vaccines. J Carbohydr Chem (2012) 0.98
A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic. J Am Chem Soc (2013) 0.96
Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine. Proc Natl Acad Sci U S A (1995) 0.95
Enhanced immune recognition of cryptic glycan markers in human tumors. Cancer Res (2009) 0.93
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients. J Transl Med (2005) 0.92
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. Br J Cancer (2004) 0.91
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90
Biosynthesis and functions of gangliosides: recent advances. Glycoconj J (1998) 0.89
Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes. Bioconjug Chem (2013) 0.89
Humoral innate immune response and disease. Clin Immunol (2012) 0.89
Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction. J Immunol (2009) 0.87
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines. J Transl Med (2004) 0.86
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy. Clin Exp Immunol (2012) 0.84
Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein. J Clin Immunol (2012) 0.82
Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun (2007) 0.81
Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues. J Clin Immunol (2000) 0.80
Therapeutic cancer vaccines: using unique antigens. Proc Natl Acad Sci U S A (2004) 0.80
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Ann Surg (1997) 0.79
Adjuvant therapy: melanoma. J Skin Cancer (2011) 0.78
Biological response modifiers in cancer. MedGenMed (2006) 0.76
Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines. Medchemcomm (2014) 0.76
Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma. Clin Exp Metastasis (2003) 0.76
Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma. BMC Vet Res (2015) 0.76
Synthesis of Biotinylated Tumor-Associated Carbohydrate Antigens for Immunological Studies. Tetrahedron Lett (2009) 0.75
Biology of human cutaneous melanoma. Cancers (Basel) (2010) 0.75
Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma. BMC Vet Res (2015) 0.75
Synthesis and characterization of a novel chemically designed (Globo)3-DTPA-KLH antigen. Drug Des Devel Ther (2014) 0.75
Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers. Biomaterials (2016) 0.75
Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies. Chembiochem (2015) 0.75
Adjuvant therapy for melanoma: How should we respond to high-dose interferon? Br J Cancer (1998) 0.75
Allylmalonamide as a bivalent linker: synthesis of biantennary GM3-saccharide--keyhole limpet hemocyanin glycoconjugate and the immune response in mice. Glycoconj J (1999) 0.75
Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966. Clin Exp Metastasis (2000) 0.75
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27
Structure of the bacteriophage phi29 DNA packaging motor. Nature (2000) 5.25
G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology (1992) 3.79
Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst (1997) 3.51
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79
Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst (1995) 2.70
In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A (1993) 2.40
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer (1999) 2.26
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides. Int J Cancer (1997) 2.13
Assay to determine plastic deformations of bones in the micron range. Res Exp Med (Berl) (1973) 2.09
Lipid synthesis under hydrothermal conditions by Fischer-Tropsch-type reactions. Orig Life Evol Biosph (1999) 2.00
Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg (1995) 1.99
Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst (1993) 1.82
Quantitation of RNA polymerase II and its transcription factors in an HeLa cell: little soluble holoenzyme but significant amounts of polymerases attached to the nuclear substructure. Mol Cell Biol (1999) 1.79
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer (1993) 1.77
Structure determination of the head-tail connector of bacteriophage phi29. Acta Crystallogr D Biol Crystallogr (2001) 1.74
The home health visit: an appropriate unit for Medicare payment? Health Aff (Millwood) (1996) 1.67
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med (2000) 1.67
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc Natl Acad Sci U S A (1999) 1.63
Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg (1995) 1.62
The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61
Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg (1986) 1.59
Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis (2010) 1.57
Transcription activation via enhanced preinitiation complex assembly in a human cell-free system lacking TAFIIs. Mol Cell (1998) 1.56
Cryoelectron-microscopy image reconstruction of symmetry mismatches in bacteriophage phi29. J Struct Biol (2001) 1.54
Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst (1992) 1.54
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer (1993) 1.52
Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer (1994) 1.50
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res (2000) 1.48
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Cancer Res (2001) 1.47
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Exposure to Helicobacter pylori infection in early childhood and the risk of allergic disease and atopic sensitization: a longitudinal birth cohort study. Clin Exp Allergy (2014) 1.46
Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg (2001) 1.45
[Experimental investigations of the elastic deformation by compression of bone diaphyses (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 1.45
[Experimental studies on the mechanical properties of bone with reference to compression osteosyntheses]. Arch Orthop Unfallchir (1973) 1.44
Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am J Clin Nutr (1997) 1.43
New hypothesis of chronic back pain: low pH promotes nerve ingrowth into damaged intervertebral disks. Acta Anaesthesiol Scand (2012) 1.43
[Biomechanical caused of loosening and breaking of the hip joint prothesess (author's transl)]. Arch Orthop Unfallchir (1973) 1.43
Prognostic significance of marked leukocytosis in hospitalized patients. J Gen Intern Med (1991) 1.42
Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet (1996) 1.41
Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery (1997) 1.40
["Zuggurtungs"-hip joint endoprosthesis (author's transl)]. Arch Orthop Unfallchir (1976) 1.39
Dietary calcium supplementation as a treatment for mild hypertension. J Am Board Fam Pract (1991) 1.39
Duane's syndrome. An electromyographic study. Arch Ophthalmol (1972) 1.38
Ongoing debate over 'complete' physicals. Postgrad Med (1999) 1.37
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci U S A (1998) 1.37
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci U S A (2000) 1.36
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1997) 1.36
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.35
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncol (1987) 1.34
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J Biol Chem (2000) 1.32
Color Doppler, power Doppler and B-flow ultrasound in the assessment of ICA stenosis: Comparison with 64-MD-CT angiography. Eur Radiol (2006) 1.30
Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev (1999) 1.30
Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. Int J Cancer (2000) 1.30
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc Natl Acad Sci U S A (1987) 1.30
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br J Cancer (2006) 1.29
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine (1994) 1.28
Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease. Circulation (1981) 1.28
The OrthoChina project. J Bone Joint Surg Br (2007) 1.26
Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription. Mol Cell Biol (2001) 1.26
Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci U S A (1992) 1.24
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer. J Clin Oncol (1993) 1.24
[Biomechanical investigations to the stability of combined osteosyntheses for pertrochanteric femur fractures (author's transl)]. Arch Orthop Unfallchir (1974) 1.22
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab (2001) 1.22
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene (2006) 1.22
Improved survival in young women with breast cancer. Ann Surg Oncol (1995) 1.21
Novel cofactors and TFIIA mediate functional core promoter selectivity by the human TAFII150-containing TFIID complex. Mol Cell Biol (1998) 1.21
Retinol is essential for growth of activated human B cells. J Exp Med (1990) 1.18
Current management of male breast cancer. A review of 104 cases. Ann Surg (1992) 1.18
[Experimental investigations to the problem of anchorage of the hip joint endoprostheses (author's transl)]. Arch Orthop Unfallchir (1973) 1.16
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma. Int J Cancer (1997) 1.15
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res (2001) 1.15
NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ (1999) 1.15
Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res (1996) 1.12
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer (2006) 1.12
Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope (1988) 1.11
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res (1995) 1.09
Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Virology (1997) 1.08
Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC. J Clin Oncol (1993) 1.07
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. J Clin Oncol (2001) 1.07
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Cancer Res (2000) 1.06
Osteoporosis in china. Osteoporos Int (2009) 1.06
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase. Br J Cancer (2011) 1.05
Purification, crystallization and initial X-ray analysis of the head-tail connector of bacteriophage phi29. Acta Crystallogr D Biol Crystallogr (2000) 1.05
Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. Cancer Res (1989) 1.04
HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res (1992) 1.04
Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease. Circulation (1985) 1.03
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol (1987) 1.03
[Parkinsonism and fitness to drive]. MMW Munch Med Wochenschr (1979) 1.03
Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res (1995) 1.03
A single peripheral injection of basic fibroblast growth factor (bFGF) stimulates granule cell production and increases cerebellar growth in newborn rats. J Neurobiol (2001) 1.02
Negatively charged nitrogen-vacancy centers in a 5 nm thin 12C diamond film. Nano Lett (2013) 1.01